| Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis (NCT03835507) | Hanyang University Seoul Hospital | 2016-06-20 |
| Phase I Trial of BAY1251152 for Advanced Blood Cancers (NCT02745743) | Bayer | 2016-06-17 |
| PA Tolerability, Safety and Pharmacokinetics in Healthy Volunteers (NCT04174937) | Scientific Center for Anti-infectious Drugs, Kazakhstan | 2016-06-17 |
| An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread (NCT02737475) | Bristol-Myers Squibb | 2016-06-17 |
| A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies (NCT02740985) | AstraZeneca | 2016-06-17 |
| Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission (NCT02365480) | National Cancer Institute (NCI) | 2016-06-16 |
| A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors (NCT02718911) | Eli Lilly and Company | 2016-06-16 |
| Pharmacokinetic and Pharmacodynamic Effects of Smoked and Vaporized Cannabis (NCT03676166) | Johns Hopkins University | 2016-06-16 |
| Study of Relugolix Alone and Relugolix Combined With Hormonal Add-Back Therapy in Healthy Premenopausal Female Participants (NCT04978688) | Myovant Sciences GmbH | 2016-06-16 |
| A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML) (NCT02632721) | Boehringer Ingelheim | 2016-06-16 |
| A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer (NCT02716116) | Takeda | 2016-06-16 |
| Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma (NCT02709226) | National Cancer Institute (NCI) | 2016-06-15 |
| Study of Pharmacokinetics, Pharmacodynamics, Safety of BCD-131 Compared to Mircera and Aranesp in Healthy Volunteers (NCT02731469) | Biocad | 2016-06-15 |
| A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer (NCT02734160) | Eli Lilly and Company | 2016-06-15 |
| Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC (NCT02795429) | Novartis Pharmaceuticals | 2016-06-15 |
| Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma (NCT02715609) | Washington University School of Medicine | 2016-06-15 |
| Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT (NCT02728895) | Takeda | 2016-06-15 |
| A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer (NCT02661815) | Dana-Farber Cancer Institute | 2016-06-15 |
| A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer (NCT02684032) | Celcuity Inc | 2016-06-14 |
| Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor. (NCT02732119) | Novartis Pharmaceuticals | 2016-06-14 |
| P.Vivax Treatment Trial (NCT02802813) | University of Oxford | 2016-06-14 |
| Study to Investigate the Pharmacokinetics, Safety and Tolerability of Odalasvir and AL-335 in Healthy Japanese Participants (NCT02821858) | Janssen Research & Development, LLC | 2016-06-14 |
| Impact of A Mobile Game on Pediatric Nutrition and Physical Activity (NCT04082195) | Center for Communication and Change India | 2016-06-14 |
| Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers (NCT02734615) | Novartis Pharmaceuticals | 2016-06-14 |
| Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy (NCT02432963) | City of Hope Medical Center | 2016-06-14 |
| A Phase I Study of CX5461 (NCT02719977) | Canadian Cancer Trials Group | 2016-06-13 |
| A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830 (NCT02751424) | GlaxoSmithKline | 2016-06-13 |
| Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants (NCT02792192) | Hoffmann-La Roche | 2016-06-13 |
| Clinical Trial In Healthy Volunteers And Health Elderly Volunteers To Evaluate The Safety, Tolerability And Blood Concentration After Single And Multiple Escalating Oral Doses Of PF-06751979. (NCT02793232) | Pfizer | 2016-06-13 |
| RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists (NCT02112565) | City of Hope Medical Center | 2016-06-13 |
| AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia (NCT02675452) | Amgen | 2016-06-13 |
| A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy (NCT02661659) | University of Chicago | 2016-06-12 |
| Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants (NCT02832362) | GlaxoSmithKline | 2016-06-11 |
| Safety Study of RMJH-111b to Treat Essential Hypertension (NCT02822222) | RMJ Holdings, LLC | 2016-06-10 |
| Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors (NCT02835833) | University of Alabama at Birmingham | 2016-06-09 |
| Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers (NCT02642809) | Washington University School of Medicine | 2016-06-08 |
| Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene Variation (NCT02639273) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2016-06-08 |
| A Study to Assess the Effects of Age and Gender on the Pharmacokinetics of JNJ-42847922 in Healthy Adults (NCT02837692) | Janssen Research & Development, LLC | 2016-06-08 |
| Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer (NCT02751918) | Bayer | 2016-06-08 |
| PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA) (NCT02702492) | Karyopharm Therapeutics Inc | 2016-06-08 |
| A Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy Subjects (NCT02797847) | Alnylam Pharmaceuticals | 2016-06-07 |
| Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence (NCT02681302) | Hackensack Meridian Health | 2016-06-07 |
| Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers (NCT05303961) | Samjin Pharmaceutical Co., Ltd. | 2016-06-07 |
| Epidural Analgesia Use in Pancreatic Resections (NCT02681796) | Washington University School of Medicine | 2016-06-07 |
| Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial (NCT03358355) | Northwestern University | 2016-06-07 |
| Administration of T Lymphocytes for Prevention of Relapse of Lymphomas (NCT02663297) | UNC Lineberger Comprehensive Cancer Center | 2016-06-07 |
| Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris (NCT02801903) | Novan, Inc. | 2016-06-07 |
| Immunologic Profile of Chronically Photodamaged Skin (NCT02889159) | University of Michigan | 2016-06-06 |
| BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer (NCT02608229) | Washington University School of Medicine | 2016-06-06 |
| Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction (NCT02474199) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-06-06 |
| DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection (NCT02772003) | National Cancer Institute (NCI) | 2016-06-06 |
| A Phase 1 Study to Evaluate PK Profile and Food Effects on PK Parameters of TNP-2092 Capsules (NCT06178718) | TenNor Therapeutics (Suzhou) Limited | 2016-06-06 |
| Phase Ib Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients (NCT02754167) | Pieris Pharmaceuticals GmbH | 2016-06-06 |
| Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study (NCT02760056) | Oregon Health and Science University | 2016-06-06 |
| Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer (NCT02560636) | Royal Marsden NHS Foundation Trust | 2016-06-06 |
| Caudal Combination of Dexamethasone and/or Dexmedetomidine to Bupivacaine in Pediatric Hypospadias Surgery (NCT03261921) | Cairo University | 2016-06-05 |
| A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy (NCT02677922) | Celgene | 2016-06-03 |
| BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study (NCT02550743) | howard safran | 2016-06-03 |
| A Study to Evaluate the Effect of Gastric pH on Acalabrutinib Pharmacokinetics (PK) in Healthy Adult Participants (NCT04905043) | Acerta Pharma BV | 2016-06-03 |
| Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted With Cobicistat in Healthy Volunteers (NCT02771249) | National Institutes of Health Clinical Center (CC) | 2016-06-03 |
| Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia (NCT02808442) | Institut de Recherches Internationales Servier | 2016-06-03 |
| Phase 1 Study of dmLT ID Vaccination in Healthy Adults (NCT02531685) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-06-02 |
| Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy Participants (NCT02833831) | Janssen Research & Development, LLC | 2016-06-02 |
| A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 Diabetes (NCT02773381) | Novo Nordisk A/S | 2016-06-02 |
| A Study to Assess the Pharmacokinetics and Safety of Different Forms and Formulations of AZD9496 in Healthy Subjects (NCT02780713) | AstraZeneca | 2016-06-02 |
| Cerebrolysin and Neurodevelopment in Preterm Infants (NCT03506841) | Mansoura University Children Hospital | 2016-06-01 |
| Drug-Drug Interaction Study of AG120 in Healthy Subjects (NCT02831972) | Agios Pharmaceuticals, Inc. | 2016-06-01 |
| Oxytocin, Trauma Disclosure and Intrusions (NCT03425929) | University Hospital, Bonn | 2016-06-01 |
| Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines (NCT02840123) | Fundació Sant Joan de Déu | 2016-06-01 |
| Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis (NCT02805244) | Akros Pharma Inc. | 2016-06-01 |
| A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects (NCT02798991) | GlaxoSmithKline | 2016-06-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002 (NCT02808793) | Allakos Inc. | 2016-06-01 |
| Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV (NCT02798692) | Hookipa Biotech GmbH | 2016-06-01 |
| Dexmedetomidine and Ketamine in MRI (NCT02652507) | Children's Hospital Medical Center, Cincinnati | 2016-06-01 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms (NCT02803268) | Tanabe Pharma Corporation | 2016-06-01 |
| Phase I Single and Multiple Escalating Dose Study of RGN1016 in Healthy Male Subjects (NCT02820155) | National Taiwan University Hospital | 2016-06-01 |
| PK Bioequivalence Single-dose Safety Tolerability Study in Healthy Male Volunteers to Compare CBT124 & Avastin(EU&US) (NCT02747823) | Cipla BioTec Pvt. Ltd. | 2016-06-01 |
| Controlled Human Malaria Infection Model for Evaluation of Transmission-Blocking Interventions - Study 1 (NCT02836002) | Radboud University Medical Center | 2016-06-01 |
| Inhaled Budesonide and Acute Mountain Sickness (NCT02811016) | Salzburger Landeskliniken | 2016-06-01 |
| Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream (NCT02849873) | Bausch Health Americas, Inc. | 2016-06-01 |
| Phase 1/2 Study of CG200745 PPA for Myelodysplastic Syndrome (NCT02737462) | CrystalGenomics, Inc. | 2016-06-01 |
| Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months (NCT02878291) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2016-06-01 |
| A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets (NCT02812394) | Acorda Therapeutics | 2016-06-01 |
| Preoperative Administration of Heparin as Thromboprophylaxis in Major Thoracic Surgery (NCT02940444) | West China Hospital | 2016-06-01 |
| Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantation (NCT02512718) | Alexandra N. Carey | 2016-06-01 |
| A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors (NCT02686944) | Mendus | 2016-06-01 |
| Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma (NCT02701673) | M.D. Anderson Cancer Center | 2016-06-01 |
| Exercise and Rehabilitation After Traumatic Brain Injury (NCT03407924) | Centre for Neuro Skills | 2016-06-01 |
| RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease (NCT02838797) | Virginia Commonwealth University | 2016-06-01 |
| BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI) (NCT02805023) | BioGenCell Ltd. | 2016-06-01 |
| Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation (NCT03014102) | Hongnan Mo | 2016-06-01 |
| A Study to Assess the Safety and Tolerability of Single and Multiple Doses of AZD4831 in Healthy Male Subjects (NCT02712372) | AstraZeneca | 2016-06-01 |
| Bioequivalence Study of Ibuprofen 200 mg/5 mL Oral Suspension vs. MOMENT 200 mg Coated Tablet (NCT02902289) | Aziende Chimiche Riunite Angelini Francesco S.p.A | 2016-06-01 |
| MapMySmoke: Smoking Cessation App With Geospatial Capture (NCT02932917) | University of St Andrews | 2016-06-01 |
| A Study to Evaluate the Effect of High Fat Meal on Cabotegravir (NCT02799264) | ViiV Healthcare | 2016-06-01 |
| A Clinical Trial of YH1177 in Patients With Otitis Media and Otorrhea (NCT02817347) | Yuhan Corporation | 2016-06-01 |
| AZD2014 Plus Novel Anti-Cancer Agents in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (NCT02780830) | AstraZeneca | 2016-06-01 |
| Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer (NCT02796898) | Tyme, Inc | 2016-06-01 |
| First In Human Safety, Pharmacokinetics and Anti-tumoral Activity of GM102 in Gynecological Cancers (NCT02978755) | GamaMabs Pharma | 2016-06-01 |
| Management of Intracerebral Hemorrhage With Aminocaproic Acid - Pilot Study (NCT02639819) | The University of Texas Health Science Center at San Antonio | 2016-06-01 |